Skip to main content
An official website of the United States government

Funded Grants

Grants awarded in the current fiscal year and carried over from prior fiscal years.

PI Name Sort descending PI Organization Title Grant Number Program Official
Chen, Ru

Baylor College Of Medicine
United States

BLOOD-BASED PROTEOMIC ASSAY FOR PANCREATIC CANCER DETECTION 4UH3CA292130-02 Claire Zhu, Ph.D.
Cheville, Andrea Lynne

Mayo Clinic Rochester
United States

Achieving Safe, Comprehensive, Digitally-Enabled Cancer Pain managemeNT” (ASCENT) Clinical Trial 5R33CA278594-04 Brennan Streck, Ph.D., RN, M.P.H.
Chibwesha, Carla J

Univ Of North Carolina Chapel Hill
United States

Acceptability and feasibility of combination treatment for cervical precancer among South Africa women living with HIV 5R01CA250850-05 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Chinnaiyan, Arul M

University Of Michigan At Ann Arbor
United States

Michigan-VUMC Biomarker Characterization Center 5U2CCA271854-04 Indu Kohaar, Ph.D., M.Phil., M.Sc.
Chirenje, Zvavahera Mike

University Of California, San Francisco
United States

Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Zimbabwe (ZIM-CASCADE) 3UG1CA284918-03S1 Maria Silvina Frech, Ph.D., M.S.
Chong, Catherine Daniela

Mayo Clinic Arizona
United States

Biomarker Signature to Predict the Persistence of Post-Traumatic Headache 5R33NS113315-03 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Chung, Raymond T

Massachusetts General Hospital
United States

Trial of Statins for Chemoprevention in Hepatocellular Carcinoma 4R01CA255621-05 Asad Umar, D.V.M., Ph.D.
Chung, Ki Young

Prisma Health - Upstate
United States

NCORP of the Carolinas (Greenville Health System NCORP) 3UG1CA189972-11S1 Vanessa A. White, M.P.H.
Chung, Michael Hoonbae

Emory University
United States

HIV/cervical cancer cOntrol and Prevention clinical sitE in Kenya (HOPE-Kenya) 3UG1CA275400-04S1 Maria Silvina Frech, Ph.D., M.S.
Clapper, Margie L.

Research Inst Of Fox Chase Can Ctr
United States

Cancer Prevention-Interception Targeted Agent Discovery Program at Fox Chase Cancer Center 5U54CA272686-04